Wegovy 2.4mg FlexTouch helps reduce the risk of major heart events, such as heart attack, stroke, and cardiovascular death, in obese or overweight adults with heart disease. It promotes weight loss and improves metabolic health and lipid profile, contributing to better heart health.
SUNDAE is a brand of Semaglutide injection (4mg/3ml) introduced for the management of Type 2 diabetes and metabolic disorders. It is a GLP-1 receptor agonist designed to be taken as a weekly subcutaneous injection.
Sembolic 14 mg tablet (containing Semaglutide) is a prescription medicine used to improve blood sugar control in adults with Type 2 diabetes mellitus. It stimulates insulin secretion, reduces sugar production by the liver, and slows digestion to manage blood sugar levels, often promoting weight loss.
